Act Capital Management, LLC Inhibikase Therapeutics, Inc. Transaction History
Act Capital Management, LLC
- $72.5 Million
- Q3 2022
A detailed history of Act Capital Management, LLC transactions in Inhibikase Therapeutics, Inc. stock. As of the latest transaction made, Act Capital Management, LLC holds 937,500 shares of IKT stock, worth $1.09 Million. This represents 1.18% of its overall portfolio holdings.
Number of Shares
937,500
Previous 937,500
-0.0%
Holding current value
$1.09 Million
Previous $696,000
22.56%
% of portfolio
1.18%
Previous 0.97%
Shares
4 transactions
Others Institutions Holding IKT
# of Institutions
2Shares Held
1.03MCall Options Held
0Put Options Held
0About Inhibikase Therapeutics, Inc.
- Ticker IKT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,227,100
- Market Cap $29.3M
- Description
- Inhibikase Therapeutics, Inc., a clinical stage pharmaceutical company, develops therapeutics for Parkinson's Disease (PD) and related disorders that arise inside and outside of the brain. The company's product candidates include IkT-148009, a small molecule Abelson tyrosine kinase inhibitor for use in the treatment of PD, as well as gastrointes...